Retatrutide is a triple agonist acting on GLP-1, GIP, and glucagon receptors, with phase 2 data published in the New England Journal of Medicine (2023) showing substantial weight reduction
View Article Oxidative Medicine and Cellular Longevity (2012) "The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging." (The major review by Loren Pickart)
BPC-157 has a well-set up research history with many published studies showing effect for many types of gut damage
Am Acad Dermatol [72nd Annual Meeting]
OVERDOSE: Overdose with this medication is very unlikely
Therapeutic response to cyanocobalamin may decrease due to elderly age, infection, renal insufficiency, diabetes mellitus, marrow suppressants use (e.g